Insulet
PODD
#1907
Rank
NZ$18.47 B
Marketcap
NZ$266.75
Share price
1.28%
Change (1 day)
-51.47%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): NZ$0.80 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.90 Billion. In 2025 the company made an earning of NZ$0.67 Billion, an increase over its 2024 earnings that were of NZ$0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.80 B18.79%
2025 NZ$0.67 B16.3%
2024 NZ$0.58 B36.76%
2023 NZ$0.42 B481.9%
2022 NZ$73.42 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$93.52 M18.51%
2019 NZ$78.91 M41.16%
2018 NZ$55.9 M-711.95%
2017 -NZ$9.14 Million-56.85%
2016 -NZ$21.18 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$62.47 Million31.04%
2013 -NZ$47.68 Million-21.96%
2012 -NZ$61.09 Million
2010 -NZ$58.27 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$91.73 Million209.75%
2006 -NZ$29.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.25 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.86 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.69 B 1,237.60%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$53.02 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.35 Billion-142.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.16 B-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$2.07 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA